Skip to main content
. 2007 Oct 17;2007(4):CD003167. doi: 10.1002/14651858.CD003167.pub3

Collignon‐Brach 1994.

Methods RCT. 
 Open label. 
 Active controlled.
Participants 19 people with OHT or POAG (n=5). 
 Racial constitution is not reported. 
 Inclusion criteria: untreated IOP of at least 20 mmHg in at least one eye. 
 Exclusion criteria: any other significant ocular pathology.
Interventions Timolol 0.5& twice daily. 
 Betaxolol 0.5% twice daily.
Outcomes Change of visual field mean sensitivity. 
 IOP.
Notes 4 years follow up. 
 Drop‐out rate was 4 of 19 patients for both groups together, not specified for the groups separately. The authors state that there was no drop‐out due to drug‐related adverse events. 
 Visual field data were averaged for both eyes of each patient.
Risk of bias
Bias Authors' judgement Support for judgement
Allocation concealment? Unclear risk B ‐ Unclear